dx.doi.org/10.1038/leu.2016.117, hdl.handle.net/1765/87082
Leukemia
Department of Hematology

Dinmohamed, A.G, van Norden, Y, van de Loosdrecht, A.A, & Jongen-Lavrencic, M. (2016). Effectiveness of azacitidine in higher-risk myelodysplastic syndromes. Leukemia, 30(8), 1795–1796. doi:10.1038/leu.2016.117